Fred Schwarzer - 13 May 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CEO and President, Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
13 May 2022
Net transactions value
+$5,125
Form type
4
Filing time
17 May 2022, 18:58:56 UTC
Previous filing
17 Mar 2022
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $5,125 +414 +1.2% $12.38 35,349 13 May 2022 Direct F1
holding IGMS Common Stock 196,718 13 May 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.